White Paper on Climate Change
Building a healthier and more environmentally sustainable future
White Paper on Climate Change
Direct or indirect human activities have altered the composition of the global atmosphere and increased carbon dioxide emissions, driving up temperatures. This has led to what we often observe as more extreme weather conditions and is referred to as climate change.
The pharmaceutical industry contributes to a healthy environment while demonstrating leadership in mitigating climate change. Our activities support the ambition the European Commission expressed through their European Climate policies. EFPIA member companies are committed to:
- Establishing climate change policies and strategies based on materiality and impact for individual companies, and addressing their entire value chains;
- Pursuing science-based CO2e reduction targets;
- Contributing to reduced energy consumption and increased energy efficiency and seeking opportunities to use energy from renewable sources throughout the value chain;
- Annually and publicly disclosing CO2 performance calculated according to recognized methodologies such as e.g. the World Resources Institute Greenhouse Gas Protocol.